The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...
A pheochromocytoma is a type of tumor found in the adrenal glands or certain nerve cells. These tumors are very rare but can cause dramatic symptoms because they tend to secrete large amounts of ...
1 Hereditary Endocrine Cancer Group, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain 2 Department of Human Genetics, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback